vs
Side-by-side financial comparison of ACV Auctions Inc. (ACVA) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
ACV Auctions Inc. is the larger business by last-quarter revenue ($183.6M vs $168.4M, roughly 1.1× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 15.1%). Over the past eight quarters, ACV Auctions Inc.'s revenue compounded faster (12.3% CAGR vs 10.6%).
ACV Auctions Inc.ACVAEarnings & Financial Report
ACV Auctions Inc. operates a leading digital wholesale vehicle auction platform serving automotive dealers across the U.S. and Canada. It offers end-to-end services including transparent vehicle inspections, secure payment processing, and logistics support, enabling efficient trading of used vehicles between registered wholesale buyers and sellers.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
ACVA vs ESPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $183.6M | $168.4M |
| Net Profit | — | — |
| Gross Margin | — | — |
| Operating Margin | -9.7% | 50.6% |
| Net Margin | — | — |
| Revenue YoY | 15.1% | 143.7% |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.12 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $183.6M | $168.4M | ||
| Q3 25 | $199.6M | $87.3M | ||
| Q2 25 | $193.7M | $82.4M | ||
| Q1 25 | $182.7M | $65.0M | ||
| Q4 24 | $159.5M | $69.1M | ||
| Q3 24 | $171.3M | $51.6M | ||
| Q2 24 | $160.6M | $73.8M | ||
| Q1 24 | $145.7M | $137.7M |
| Q4 25 | — | — | ||
| Q3 25 | $-24.5M | $-31.3M | ||
| Q2 25 | $-7.3M | $-12.7M | ||
| Q1 25 | $-14.8M | $-40.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-16.0M | $-29.5M | ||
| Q2 24 | $-17.1M | $-61.9M | ||
| Q1 24 | $-20.5M | $61.0M |
| Q4 25 | -9.7% | 50.6% | ||
| Q3 25 | -11.9% | -11.4% | ||
| Q2 25 | -3.7% | 8.6% | ||
| Q1 25 | -7.9% | -34.0% | ||
| Q4 24 | -16.2% | -6.4% | ||
| Q3 24 | -10.0% | -31.0% | ||
| Q2 24 | -11.6% | 3.5% | ||
| Q1 24 | -15.5% | 52.5% |
| Q4 25 | — | — | ||
| Q3 25 | -12.3% | -35.9% | ||
| Q2 25 | -3.8% | -15.4% | ||
| Q1 25 | -8.1% | -62.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | -9.4% | -57.2% | ||
| Q2 24 | -10.6% | -83.9% | ||
| Q1 24 | -14.1% | 44.3% |
| Q4 25 | $-0.12 | $0.32 | ||
| Q3 25 | $-0.14 | $-0.16 | ||
| Q2 25 | $-0.04 | $-0.06 | ||
| Q1 25 | $-0.09 | $-0.21 | ||
| Q4 24 | $-0.15 | $-0.14 | ||
| Q3 24 | $-0.10 | $-0.15 | ||
| Q2 24 | $-0.10 | $-0.33 | ||
| Q1 24 | $-0.13 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $271.5M | $167.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $429.7M | $-302.0M |
| Total Assets | $1.1B | $465.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $271.5M | $167.9M | ||
| Q3 25 | $265.3M | $92.4M | ||
| Q2 25 | $258.4M | $86.1M | ||
| Q1 25 | $291.9M | $114.6M | ||
| Q4 24 | $224.1M | $144.8M | ||
| Q3 24 | $252.5M | $144.7M | ||
| Q2 24 | $215.0M | $189.3M | ||
| Q1 24 | $209.8M | $226.6M |
| Q4 25 | $429.7M | $-302.0M | ||
| Q3 25 | $434.4M | $-451.4M | ||
| Q2 25 | $448.8M | $-433.5M | ||
| Q1 25 | $439.6M | $-426.2M | ||
| Q4 24 | $440.0M | $-388.7M | ||
| Q3 24 | $456.2M | $-370.2M | ||
| Q2 24 | $457.6M | $-344.2M | ||
| Q1 24 | $458.3M | $-294.3M |
| Q4 25 | $1.1B | $465.9M | ||
| Q3 25 | $1.2B | $364.0M | ||
| Q2 25 | $1.1B | $347.1M | ||
| Q1 25 | $1.2B | $324.0M | ||
| Q4 24 | $984.1M | $343.8M | ||
| Q3 24 | $1.0B | $314.1M | ||
| Q2 24 | $1.0B | $352.3M | ||
| Q1 24 | $1.0B | $373.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-12.4M | $45.2M |
| Free Cash FlowOCF − Capex | $-14.7M | — |
| FCF MarginFCF / Revenue | -8.0% | — |
| Capex IntensityCapex / Revenue | 1.2% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $69.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-12.4M | $45.2M | ||
| Q3 25 | $10.3M | $-4.3M | ||
| Q2 25 | $13.7M | $-31.4M | ||
| Q1 25 | $66.6M | $-22.6M | ||
| Q4 24 | $-3.2M | $-35.0M | ||
| Q3 24 | $21.1M | $-35.3M | ||
| Q2 24 | $4.5M | $-7.2M | ||
| Q1 24 | $43.0M | $53.8M |
| Q4 25 | $-14.7M | — | ||
| Q3 25 | $7.7M | — | ||
| Q2 25 | $10.9M | — | ||
| Q1 25 | $65.3M | — | ||
| Q4 24 | $-3.9M | — | ||
| Q3 24 | $20.2M | $-35.5M | ||
| Q2 24 | $2.7M | $-7.3M | ||
| Q1 24 | $41.9M | $53.8M |
| Q4 25 | -8.0% | — | ||
| Q3 25 | 3.8% | — | ||
| Q2 25 | 5.6% | — | ||
| Q1 25 | 35.7% | — | ||
| Q4 24 | -2.5% | — | ||
| Q3 24 | 11.8% | -68.7% | ||
| Q2 24 | 1.7% | -9.9% | ||
| Q1 24 | 28.8% | 39.0% |
| Q4 25 | 1.2% | 0.0% | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 1.5% | 0.0% | ||
| Q1 25 | 0.7% | 0.0% | ||
| Q4 24 | 0.4% | 0.0% | ||
| Q3 24 | 0.6% | 0.3% | ||
| Q2 24 | 1.1% | 0.1% | ||
| Q1 24 | 0.7% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACVA
| Auction Marketplace Revenue | $77.6M | 42% |
| Other Marketplace Revenue | $72.4M | 39% |
| Customer Assurance | $24.1M | 13% |
| Data Services Revenue | $9.4M | 5% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
